Hepatitis C treatment outcomes among people who inject drugs accessing harm reduction settings in Kenya-Reference-Cited by-同舟云学术

Hepatitis C treatment outcomes among people who inject drugs accessing harm reduction settings in Kenya

Published:2022-03-15 Issue:8 Volume:29 Page:691-694
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Akiyama Matthew J.¹^ORCID,Riback Lindsey R.¹^ORCID,Nyakowa Mercy²,Musyoki Helgar²,Lizcano John A.³,Muller Abbe³,Zhang Chenshu¹,Walker Josephine G.⁴,Stone Jack⁴,Vickerman Peter⁴^ORCID,Cherutich Peter²,Kurth Ann E.³

Affiliation:

1. Department of Medicine Montefiore Medical Center Albert Einstein College of Medicine Bronx New York USA

2. Kenya Ministry of Health National AIDS&STI Control Program (NASCOP) Nairobi Kenya

3. Yale University School of Nursing Orange Connecticut USA

4. University of Bristol Bristol UK

Funder

National Institute on Drug Abuse

National Institute on Minority Health and Health Disparities

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13662

Reference9 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

3. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030

4. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polysubstance Use and Related Risk Behaviors among People Who Inject Drugs in Kenya Preparing for Hepatitis C Virus Treatment;Viruses;2024-08-10

2. HCV‐HIV co‐infection in people who inject drugs: Barriers to treatment and cure of HCV infection in the era of DAAs, a prospective study in Athens, Greece;HIV Medicine;2024-06-20

3. Healthcare provider perspectives on the facilitators, barriers and unexplored opportunities to support the recovery of clients on medications for opioid use disorder in Kenya;Discover Health Systems;2024-02-08

4. A community-based strategy to eliminate hepatitis C among people who inject drugs in Vietnam;The Lancet Regional Health - Western Pacific;2023-08

5. Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya;International Journal of Drug Policy;2023-03